Skip to content

Effect of Experience Sharing and Mutual Assistance on Insight and Recovery During the First Psychotic Episode

Effect of Experience Sharing and Mutual Assistance on Insight and Recovery During the First Psychotic Episode

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06263933
Acronym
DIPEM
Enrollment
50
Registered
2024-02-16
Start date
2023-11-13
Completion date
2025-11-13
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic Episode

Keywords

retablishment, insight, mutual assistance, peer helper, psychiatric hospitalization, first psychotic episode

Brief summary

Controlled, prospective, qualitative and quantitative trial. The goal of this trial is to evaluate the mutual assistance early intervention device efficacy and its impact on insight and personal recovery of participants living with a first psychotic episode. This intervention lasts 5 days with 1 session per day of 1 hour 30 minutes. Three evaluations, before the intervention, after intervention and 1 month after the hospitalization's end.

Interventions

OTHERInsight Scale

Before the patient was in DIPEM or control group and after the patient is involved in DIPEM or control group

OTHERSemi-directional interviews

In the end of the intervention. In the end of DIPEM Or in the end of control group. This intervention will be held after one month of hospitalization.

OTHERroutine care

routine care

OTHERsession of mutual assistance with a mediator psychologist

session of mutual assistance with a mediator psychologist

Sponsors

Centre hospitalier de Ville-Evrard, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

A control group and a intervention group

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Man or woman between 18 and 40 years old * First psychotic episode under the guidance of a doctor * Brief psycotic trouble (SM-V) * Presenting a first psychiatry hospitalization (all modalities hospitalizations combined) * Fluent in French language (read and written) * Patient affiliated to a social protection system or beneficiary of Medical Aid of State * Patient having signed informed consent for his participation in the protocol

Exclusion criteria

* Patients whose clinical condition does not allow them to participate in research * Patients placed in isolation rooms during the intervention

Design outcomes

Primary

MeasureTime frameDescription
The level of the increasing of The INSIGHT scaleat baseline (T0) and at 5 days after the intervention's beginning (T1).Used the Echelle de conscience de trouble - insight scale. There are 8 items, with 3 choices for each items : agree, disagree, unsure. The time is 5 minutes. Maximum score = 12, very good Insight Minimum score= 0, No Insight 9 and more= good insight

Secondary

MeasureTime frameDescription
The increase of Recovery ScaleAt baseline (T0) and at 5 days after the intervention's beginning (T1).Scale of recovery Stage of recovery instrument (STORI). The time is 25 minutes. There are 5 dimensions of recovery, with 10 groups of questions, with 50 items in total. There is 5 choices for each items, with 0 to 2 for not at all true currently and 3 to 5 is completely true currently.
The semi-structured interviewAt baseline (T0) and at 1 month after the hospitalization's end (T2).For the first semi-structured interview, with 11 questions on 3 themes : the crisis course and the hospitalization, the role of peers during hospitalization and finally afterwards hospitalization. For the second semi-structured interview, there are 13 questions with 4 themes : the hospitalization living, psychosocial functioning, trouble awareness and management of symptoms.

Countries

France

Contacts

Primary ContactRusheenthira Thavaseelan
r.thavaseelan@epsve.fr0143093232
Backup Contactmathilde Pistre
m.pistre@epsve.fr0143093232

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026